论文部分内容阅读
目的:分析评价对肝硬化上消化道出血患者采用奥曲肽联合普萘洛尔治疗的临床效果。方法:选取2013年9月至2014年9月我院收治的肝硬化上消化道出血患者92例作为研究对象,随机分配为对照组(46例)、实验组(46例),对照组患者单纯予以奥曲肽治疗,实验组患者则接受奥曲肽联合普萘洛尔治疗,对比两组患者治疗后的临床疗效及不良反应发生情况。结果:经不同治疗后,实验组的临床有效率高于对照组,两组数据存在显著差异,P值均<0.05,可以构成统计学意义;结论:在临床上应用奥曲肽联合普萘洛尔治疗肝硬化上消化道出血,疗效可观,安全性高,建议在临床上推广使用。
Objective: To evaluate the clinical effect of octreotide combined with propranolol in patients with cirrhosis and upper gastrointestinal bleeding. Methods: Ninety-two patients with cirrhosis and upper gastrointestinal bleeding admitted from September 2013 to September 2014 in our hospital were randomly divided into control group (46 cases), experimental group (46 cases) and control group To octreotide treatment, patients in the experimental group received octreotide combined with propranolol treatment, comparing the two groups of patients after treatment of clinical efficacy and adverse reactions. Results: After treatment, the clinical efficiency of the experimental group was higher than that of the control group, there was significant difference between the two groups (P <0.05) .Conclusion: In the clinical application of octreotide combined with propranolol Cirrhosis of the upper gastrointestinal bleeding, considerable efficacy, high safety, it is recommended to promote the use of the clinic.